This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of drugs targeting central nervous system (CNS) disorders, including anxiety, depression, and other neurological conditions. Its structure, featuring a trifluoromethyl group, enhances the bioavailability and metabolic stability of the resulting drugs. Additionally, it is employed in the study of receptor binding interactions, aiding in the design of more effective and selective therapeutic agents. Its application extends to preclinical studies, where it helps in understanding the pharmacokinetics and pharmacodynamics of potential drug candidates.